Gaucho Says He Has No Monetary Benefits From Being In Mama Lucy Hospital Board, Shares Allowances
img_tag = ("Calvince Okoth, the controversial social media personality known as "Gaucho," is fighting back hard against Kenyans questioning why he sits on Mama Lucy Hospital's board, insisting he pockets zero shillings from the prestigious appointment.
The outspoken content creator reveals he receives only sitting allowances during board meetings at the Eastlands referral hospital, dismissing critics who suggest he landed the position for personal gain. Okoth, who has become a polarizing figure online, addresses mounting pressure from Kenyans who question his medical qualifications for overseeing one of Nairobi's busiest public hospitals.
His appointment to the Mama Lucy board earlier this year sparked fierce debate across social media platforms, with many Nairobians arguing that hospital governance should remain in the hands of qualified medical professionals. The facility serves thousands of residents from Eastlands estates like Kayole, Umoja, and Pipeline, making any leadership decisions deeply personal for families who depend on its services.
Critics point out that board positions at major public hospitals typically go to individuals with healthcare backgrounds or extensive management experience in medical settings. From Mama Lucy to Kenyatta National Hospital, Kenyans expect their health institutions to be guided by people who understand the life-and-death nature of medical decisions, not social media fame.
The controversy reflects broader frustrations about political appointments in Kenya's healthcare system, where ordinary citizens often struggle with long queues, drug shortages, and inadequate services. When someone's grandmother waits hours for treatment or a matatu accident victim needs emergency care, the competence of hospital leadership becomes more than just academic debate.
Gaucho's defense comes as public hospitals face increasing scrutiny over governance and service delivery, with many Kenyans demanding transparency in how board members are selected. Will his clarification satisfy critics, or does this controversy signal deeper problems with how we choose leaders for our most critical health institutions?